Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 1.000 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.593 | |
| 4agw | NG7 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.556 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.546 | |
| 2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.540 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.532 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.529 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.527 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.526 | |
| 3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.523 | |
| 1og5 | SWF | Cytochrome P450 2C9 | / | 0.520 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.517 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.516 | |
| 1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.512 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.511 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.505 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.504 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.503 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.499 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.499 | |
| 4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.498 | |
| 3rey | XAC | Adenosine receptor A2a | / | 0.498 | |
| 2qd5 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.496 | |
| 5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.495 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.495 | |
| 3rfm | CFF | Adenosine receptor A2a | / | 0.495 | |
| 4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.494 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.493 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.492 | |
| 3ce3 | 1FN | Hepatocyte growth factor receptor | 2.7.10.1 | 0.491 | |
| 3dko | IHZ | Ephrin type-A receptor 7 | 2.7.10.1 | 0.489 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.488 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.487 | |
| 3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.487 | |
| 5g53 | NEC | Adenosine receptor A2a | / | 0.485 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.484 | |
| 3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.483 | |
| 3uvv | REA | Retinoic acid receptor RXR-alpha | / | 0.483 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.483 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.483 | |
| 4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.483 | |
| 3fzs | B96 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.482 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.482 | |
| 3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.481 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.481 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.481 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.479 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.479 | |
| 4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.478 | |
| 3bfa | 9OD | Odorant binding protein ASP1 | / | 0.477 | |
| 3d74 | NBB | Pheromone-binding protein ASP1 | / | 0.477 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.476 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.476 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.476 | |
| 4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.476 | |
| 4rh1 | 0TT | Spore photoproduct lyase | / | 0.476 | |
| 2gvc | FAD | Thiol-specific monooxygenase | 1.14.13 | 0.475 | |
| 4dsc | A8S | Abscisic acid receptor PYL3 | / | 0.475 | |
| 2xvw | 9NR | Serum albumin | / | 0.474 | |
| 2ydo | ADN | Adenosine receptor A2a | / | 0.474 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.474 | |
| 3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.474 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.474 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.474 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.473 | |
| 3d75 | NBB | Pheromone-binding protein ASP1 | / | 0.470 | |
| 3l6j | Z90 | Alr2278 protein | / | 0.470 | |
| 4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.470 | |
| 3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 3p9t | TCL | Repressor | / | 0.469 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.469 | |
| 4klr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.469 | |
| 5bp9 | SAH | Putative methyltransferase protein | / | 0.469 | |
| 3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.468 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.468 | |
| 4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.468 | |
| 2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.467 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.467 | |
| 3f82 | 353 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.466 | |
| 4j52 | 1J3 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.466 | |
| 2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.465 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.465 | |
| 3k47 | D09 | Dihydrofolate reductase | 1.5.1.3 | 0.465 | |
| 3vg9 | ZMA | Adenosine receptor A2a | / | 0.465 | |
| 4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 4jqh | 1MF | Alr2278 protein | / | 0.465 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.465 | |
| 2owb | 626 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.463 | |
| 2rab | NAD | Glutathione amide reductase | / | 0.463 | |
| 2xk8 | 5R1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.463 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.463 | |
| 2xvv | 9DN | Serum albumin | / | 0.461 | |
| 3irx | UDR | Gag-Pol polyprotein | 2.7.7.49 | 0.461 | |
| 1m79 | MQ1 | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
| 2xk4 | OL2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.460 | |
| 3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.460 | |
| 4iah | 1DX | Alr2278 protein | / | 0.460 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.460 | |
| 1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.459 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 3d73 | NBB | Pheromone-binding protein ASP1 | / | 0.459 | |
| 1u0h | ONM | Adenylate cyclase type 2 | / | 0.458 | |
| 1u0h | ONM | Adenylate cyclase type 5 | / | 0.458 | |
| 1x8l | OXR | Retinol dehydratase | / | 0.458 | |
| 1zga | HMK | Isoflavone 4'-O-methyltransferase | / | 0.458 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
| 4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.458 | |
| 1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.457 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.457 | |
| 2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.457 | |
| 2zcq | B65 | Dehydrosqualene synthase | / | 0.457 | |
| 3gb4 | D3M | DdmC | / | 0.457 | |
| 3oap | REA | Retinoic acid receptor RXR-alpha | / | 0.457 | |
| 4fcd | 0T6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.457 | |
| 4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.457 | |
| 4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.457 | |
| 2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.456 | |
| 3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.456 | |
| 3eel | 53T | Uncharacterized protein | / | 0.456 | |
| 2gjn | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.455 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.455 | |
| 3c3d | FO1 | 2-phospho-L-lactate transferase | / | 0.455 | |
| 3u8h | BHP | Phospholipase A2, membrane associated | / | 0.455 | |
| 4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.455 | |
| 4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.455 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.455 | |
| 5ckw | ANP | Uncharacterized protein | / | 0.455 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.455 | |
| 2bxq | IMN | Serum albumin | / | 0.454 | |
| 2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.454 | |
| 3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.454 | |
| 4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.454 | |
| 4gi2 | NAP | Crotonyl-CoA carboxylase/reductase | / | 0.454 | |
| 4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.454 | |
| 1lb9 | DNQ | Glutamate receptor 2 | / | 0.453 | |
| 1xls | REA | Retinoic acid receptor RXR-alpha | / | 0.453 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.453 | |
| 2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.453 | |
| 2ydv | NEC | Adenosine receptor A2a | / | 0.453 | |
| 3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.453 | |
| 4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.453 | |
| 4m8e | 29V | Retinoic acid receptor RXR-alpha | / | 0.453 | |
| 1ia4 | TQ6 | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
| 1rgs | CMP | cAMP-dependent protein kinase type I-alpha regulatory subunit | / | 0.452 | |
| 3qlw | N22 | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
| 1ia1 | TQ3 | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
| 2acw | UPG | Glycosyltransferase | / | 0.451 | |
| 2dw4 | FAD | Lysine-specific histone demethylase 1A | 1 | 0.451 | |
| 3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.451 | |
| 3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.451 | |
| 3up3 | XCA | aceDAF-12 | / | 0.451 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.451 | |
| 5iw5 | NMN | NADH pyrophosphatase | / | 0.451 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.450 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.450 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.450 | |
| 1k74 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.449 | |
| 2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.449 | |
| 3aba | FLI | Cytochrome P450 | / | 0.449 | |
| 3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.449 | |
| 3d78 | NBB | Pheromone-binding protein ASP1 | / | 0.449 | |
| 4k4j | 1O8 | Retinoic acid receptor RXR-alpha | / | 0.449 | |
| 1dis | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
| 1efa | NPF | Lactose operon repressor | / | 0.448 | |
| 1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.448 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.448 | |
| 3ar5 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.448 | |
| 3ar6 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.448 | |
| 3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.448 | |
| 3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.448 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.448 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.448 | |
| 4gqk | ADP | Actin cross-linking toxin VgrG1 | / | 0.448 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.448 | |
| 1ps9 | MDE | 2,4-dienoyl-CoA reductase | 1.3.1.34 | 0.447 | |
| 2bxo | OPB | Serum albumin | / | 0.447 | |
| 3gie | ACP | Sensor histidine kinase DesK | 2.7.13.3 | 0.447 | |
| 3ics | ADP | Coenzyme A disulfide reductase | / | 0.447 | |
| 3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.447 | |
| 3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
| 3t5i | SER_SER_CMT_FAR | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.447 | |
| 5akk | 1P8 | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.447 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
| 3ans | S38 | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.446 | |
| 3b9l | AZZ | Serum albumin | / | 0.446 | |
| 3p2o | NAD | Bifunctional protein FolD | / | 0.446 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
| 4dc0 | NDP | Putative ketoacyl reductase | 1.3.1 | 0.446 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
| 4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
| 3jwm | 5WB | Dihydrofolate reductase | / | 0.445 | |
| 3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.445 | |
| 4htx | 19F | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.445 | |
| 4kfj | 1R0 | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 4l17 | DNQ | Glutamate receptor 2 | / | 0.445 | |
| 5dp2 | NAP | CurF | / | 0.445 | |
| 5i2h | AGI | O-methyltransferase family 2 | / | 0.445 | |
| 1xdk | REA | Retinoic acid receptor beta | / | 0.444 | |
| 2bxm | IMN | Serum albumin | / | 0.444 | |
| 2e9d | B76 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.444 | |
| 2j0v | GDP | Rac-like GTP-binding protein ARAC7 | / | 0.444 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.444 | |
| 3ar7 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.444 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.444 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.444 | |
| 4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
| 4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.444 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.444 | |
| 1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
| 1w4z | NAP | Putative ketoacyl reductase | 1.3.1 | 0.443 | |
| 1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 2uag | UMA | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.443 | |
| 2z3u | CRR | Cytochrome P450 | / | 0.443 | |
| 3c1x | CKK | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
| 3cr7 | PPS | Adenylyl-sulfate kinase | 2.7.1.25 | 0.443 | |
| 3htj | ET | EbrA repressor | / | 0.443 | |
| 3jw5 | TOP | Dihydrofolate reductase | / | 0.443 | |
| 3uic | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.443 | |
| 4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
| 4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.443 | |
| 4j4v | SVR | Nucleocapsid protein | / | 0.443 | |
| 1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
| 1xuo | LA1 | Integrin alpha-L | / | 0.442 | |
| 1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.442 | |
| 2rht | C1E | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase | 3.7.1.8 | 0.442 | |
| 2wqo | VGK | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.442 | |
| 3d84 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 3h4v | NAP | Pteridine reductase 1 | 1.5.1.33 | 0.442 | |
| 3hcr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
| 3ict | ADP | Coenzyme A disulfide reductase | / | 0.442 | |
| 3wsb | RWZ | Farnesyltransferase, putative | / | 0.442 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.442 | |
| 1h36 | R88 | Squalene--hopene cyclase | 4.2.1.129 | 0.441 | |
| 1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
| 2vd0 | D27 | Hematopoietic prostaglandin D synthase | / | 0.441 | |
| 2y30 | SM8 | Putative repressor SimReg2 | / | 0.441 | |
| 3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
| 3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.441 | |
| 3ntg | D72 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.441 | |
| 3vru | YS3 | Vitamin D3 receptor | / | 0.441 | |
| 3w0h | W12 | Vitamin D3 receptor | / | 0.441 | |
| 4iae | 1DX | Alr2278 protein | / | 0.441 | |
| 4kbn | 25U | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 4mpr | TPP | Benzoylformate decarboxylase | 4.1.1.7 | 0.441 | |
| 4yx6 | FMN | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.441 | |
| 5ai5 | BSU | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.441 | |
| 5c6c | CMP | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.441 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.441 | |
| 1yc2 | NAD | NAD-dependent protein deacylase 2 | / | 0.440 | |
| 2yiu | SMA | Cytochrome b | / | 0.440 | |
| 3bjh | NBB | Odorant binding protein ASP1 | / | 0.440 | |
| 3nal | DBK | Calcium-transporting ATPase | / | 0.440 | |
| 4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.440 |